MedPath

The added value of frequent intestinal ultrasonography in the close monitoring of moderate-severe ulcerative colitis

Recruiting
Conditions
lcerative colitis, inflammatory bowel diseases
Registration Number
NL-OMON22303
Lead Sponsor
one
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
54
Inclusion Criteria

•Ulcerative colitis, histologically and endoscopically confirmed
•Endoscopically moderate to severe disease with a eMayo score =2
•Start of medical treatment
•>18 years of age

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in this study:
•Proctitis only
•Colonic stricture at baseline endoscopy
•Imminent need of surgery
•Sigmoidoscopy/colonoscopy older than eight weeks
•Ongoing gastroenteritis
•Cytomegalovirus (CMV) associated colitis
•Obesity (BMI >35 kg/m²)
•A normal bowel wall < 2mm at baseline ultrasonography

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The main endpoint of this study will be change in bowel wall width in millimetres within 0 to 26 weeks against the reference standard of endoscopy where response on endoscopy is defined as a decrease of at least 1 point in eMayo-score at follow-up endoscopy after 8 to 26 weeks.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath